Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2601 of 5804
-
Hidden deficiencies in black college athletes under the microscope
Knowledge-focused CompletedThe purpose of this study is to determine what percentage of Black collegiate athletes have low energy availability. It will also determine the percentage of Black collegiate athletes who have iron deficiency, suboptimal or low Vitamin D levels, and may be at risk for male and fe…
Phase: NA • Sponsor: Morehouse School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New malaria prevention combo tested in mali infants
Prevention OngoingThe purpose of this study is to assess the safety, tolerability, and pharmacokinetics of L9LS in infants in Mali and to evaluate the impact of L9LS on subsequent R21/Matrix-MTM vaccine immunogenicity.
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Lab-Made albumin could replace donor protein for liver patients
Disease control CompletedThis trial adopts random, double-blind, positive control, parallel group design to evaluate the effectiveness and safety of recombinant human serum albumin versus human serum albumin in hepatic cirrhosis patients with ascites.
Phase: PHASE2, PHASE3 • Sponsor: Protgen Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill takes on rare salivary gland and colon cancers
Disease control Recruiting nowPhase 1 study to evaluate safety, tolerability and anti-tumor activity of RGT-61159 in patients with ACC or CRC
Phase: PHASE1 • Sponsor: Rgenta Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New pill shows promise for tough eczema in small study
Disease control CompletedThis is a Phase 2 open label study of ATI-2138 in participants with moderate to severe atopic dermatitis.
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Hormone pill may block bad memories after trauma
Knowledge-focused Recruiting nowThe aim of the current project is to investigate the impact of 3mg of oral estradiol valerate on the formation of intrusive memories after analog trauma. A well-established stress-film paradigm will be used to induce intrusive symptoms in healthy participants. In a double-blind …
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New drug targets immune overdrive in six rare diseases
Disease control Recruiting nowThis Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a inhibitor of classical complement pathway, after multiple dose administration in patients with immunological diseases suc…
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Booster shot for typhoid: could it protect kids for years?
Disease control CompletedThis study evaluated the persistence of immunity following primary typhoid conjugate vaccination in early childhood and assessed the immunogenicity and safety of a booster dose administered 5-6 years later. Children previously enrolled in a Phase 2 randomized clinical trial of Vi…
Phase: PHASE2 • Sponsor: Kathleen Neuzil • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a short video boost HPV shots in college students?
Prevention Recruiting nowHPV vaccines offer hope against HPV-associated cancers for males and females; however, the rate of vaccination has not reached projected public health goals. This study will engage key stakeholders in the research process to co-design and pilot testing a video-based intervention …
Phase: NA • Sponsor: Michigan State University • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Can a coach in the ER help people beat addiction?
Disease control CompletedThis is a 3-arm randomized controlled trial. Participants will be randomized via a maximally tolerated imbalance randomization procedure using NCI's Clinical Trial Randomization Tool with 1:1:1 allocation to each group: in-person peer recovery coaching (PRC) with linkage to recov…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New injection could help heart failure patients shed excess fluid
Symptom relief CompletedThe study is an open-label, Tolvaptan-controlled Phase I study to evaluate the safety, tolerability, PK/PD profile and efficacy of HRS-9057 in the treatment of heart failure with volume overload. A total of 24 subjects who experience volume overload due to heart failure despite d…
Phase: PHASE1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Can group CBT help quiet the voices and fears of psychosis?
Symptom relief ENROLLING_BY_INVITATIONSchizophrenia is a serious psychiatric disorder characterized by delusions, hallucinations, negative symptoms and disorganized behaviour. Antipsychotic medication is the main treatment for schizophrenia, but many people do not respond to treatment, and most who do respond continu…
Phase: NA • Sponsor: The Royal Ottawa Mental Health Centre • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New program aims to boost quality of life for lung cancer survivors in rural areas
Symptom relief Recruiting nowThe overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors …
Phase: NA • Sponsor: Jerod L Stapleton, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Simple heparin dressing may reduce scars and pain after skin grafts
Disease control CompletedThis study is testing whether applying a special dressing soaked with heparin (a medicine that improves blood flow and reduces scar formation) can help prevent thick, raised scars (called hypertrophic scars) and reduce pain at the site where skin is taken for a split-thickness sk…
Phase: NA • Sponsor: Dr. Ruth K.M. Pfau Civil Hospital, Karachi • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New program aims to ease heart failure burden in older adults
Symptom relief OngoingUsing a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this randomized factorial pilot trial is to identify feasibility, acceptability, and preliminary efficacy of components of an intervention (UPHOLDS) to improve quality of life of ol…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Blood test and patient surveys aim to outsmart vulva cancer recurrence
Knowledge-focused Recruiting nowThe overall aim is to investigate different aspects of recurrence detection in women with vulva cancer (VC) to identify optimal treatment- and surveillance programs. DaVulvaRec is a Danish nationwide multicenter study with patient inclusion from Aarhus University Hospital and Ri…
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Talking it out: psychotherapy shows promise for depressed breast cancer patients
Symptom relief CompletedThis study is planned to examine the effect of Interpersonal Relationship Psychotherapy on depression, interpersonal emotion regulation and multidimensional perceived social support levels of breast cancer patients with depression risk.
Phase: NA • Sponsor: Koç University • Aim: Symptom relief
Last updated Jun 26, 2026 14:56 UTC
-
New hope for dialysis patients who can't use standard blood thinners
Disease control Recruiting nowA prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at h…
Phase: NA • Sponsor: Talphera, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Needles vs. cancer: acupuncture may supercharge immunotherapy
Symptom relief OngoingThis multicentre, randomized controlled trial evaluates the effect and safety of integrating acupuncture with immunotherapeutic sensitization in treating NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial fo…
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Leg heat therapy shows promise for heart failure patients
Symptom relief Recruiting nowThe objective of this pilot study is to establish evidence to support the validity of HT in improving skeletal muscle function and physical capacity of patients with HFpEF. Our central hypothesis is that HT treatment will lead to improvements in skeletal muscle and microvascular …
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC